Vice President Quality Assurance
City Therapeutics
Vice President Quality Assurance
City Therapeutics
Develops RNAi therapeutics using trigger molecules
Vice President, Quality Assurance
City Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients with serious unmet medical needs. As we progress our pipeline through critical regulatory and clinical milestones, we are seeking a seasoned VP of Quality Assurance to lead and own our quality assurance strategy and systems across the organization.
The Vice President, Quality Assurance will be the senior quality leader at City Therapeutics, responsible for the design, implementation, and continuous improvement of the company's Quality Management System (QMS) and all quality assurance functions. This individual will ensure that all development, manufacturing, and clinical activities are conducted in full compliance with cGXP regulations, applicable regulatory guidance, and internal standards. As a key member of the leadership team, the VP of QA will embed a culture of quality across the organization and ensure the company is perpetually inspection-ready.
Key Responsibilities:
Quality Strategy & Leadership
cGXP Compliance
Regulatory Inspections & Agency Interactions
Supplier, CMO & CRO Oversight
Cross-Functional Partnership
Qualifications:
Preferred
Our Working Model: In Person, By Design
At City, we believe that science and culture thrive together, and that happens best in person. Our working model is clear: we work onsite at our Kendall Square offices five days per week. This choice reflects our belief that great science and cultures run on connection, fairness, and growth.
Compensation
The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package. Pay range is $340,000 to $360,000
City Therapeutics is an Equal Opportunity and Affirmative Action employer. All qualified applicants will receive consideration without regard to race, color, religion, national origin, gender, gender identity or expression, sexual orientation, age, disability, veteran status, or any other characteristic protected by law.
City Therapeutics is accepting resumes/CVs from direct applicants only. Recruitment Agency submissions will not be accepted at this time.
Develops RNAi therapeutics using trigger molecules
City Therapeutics develops RNA interference (RNAi) medicines. It works on creating next-generation trigger molecules and delivery ligands to silence disease-causing genes in the body. The core product approach uses RNAi to turn off specific genes in cells, reducing the production of harmful proteins. Delivery and targeting are tailored, so the RNAi triggers reach the right tissues more effectively than before. Compared with peers, City Therapeutics emphasizes proprietary trigger chemistry and ligand-based delivery to improve precision and expand the range of diseases that can be treated, aiming for strong therapeutic impact rather than relying on traditional small molecules or antibodies. The company’s goal is to advance and apply RNAi-based medicines across multiple conditions by leveraging human genetics insights, partnerships, and focused development to bring effective gene-silencing therapies to patients.
Explore more opportunities at City Therapeutics